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Abstract
Currently no national guidelines exist for the management of scabies outbreaks in residential
or nursing care homes for the elderly in the United Kingdom. In this setting, diagnosis and
treatment of scabies outbreaks is often delayed and optimal drug treatment, environmental
control measures and even outcome measures are unclear. We undertook a systematic review
to establish the efficacy of outbreak management interventions and determine evidence-based
recommendations. Four electronic databases were searched for relevant studies, which were
assessed using a quality assessment tool drawing on STROBE guidelines to describe the qual-
ity of observational data. Nineteen outbreak reports were identified, describing both drug
treatment and environmental management measures. The quality of data was poor; none
reported all outcome measures and only four described symptom relief measures. We were
unable to make definitive evidence-based recommendations. We draw on the results to pro-
pose a framework for data collection in future observational studies of scabies outbreaks.
While high-quality randomised controlled trials are needed to determine optimal drug treat-
ment, evidence on environmental measures will need augmentation through other literature
studies. The quality assessment tool designed is a useful resource for reporting of outcome
measures including patient-reported measures in future outbreaks.
Introduction
Scabies is a common and disabling dermatological condition caused by infestation with the
mite Sarcoptes scabiei [1–3]. Designated as a Neglected Tropical Disease by the World
Health Organization, it remains an important public health issue in the United Kingdom
(UK) [4], especially in institutional settings such as residential or nursing care homes for
the elderly (RNC), where outbreaks are typically prolonged, recognition is often delayed
and management is highly challenging [1, 5, 6].
Scabies is mainly spread through direct skin to skin contact, and less commonly through
fomites. Symptoms tend to present 4–6 weeks after exposure due to a delayed hypersensitivity
reaction to the scabies mites’ faeces and eggs, or within a week if after repeated infestation
[3, 7, 8]. The classical presentation is an erythematous papular rash and pruritus, which is typ-
ically worse at night [3, 9].
The elderly, young and immunocompromised are particularly vulnerable to scabies [10,
11], and RNC are especially susceptible to institutional outbreaks [12]. The typical distribution
of clinical signs may differ in the elderly [8, 13, 14]; residents may be asymptomatic or have
subtle signs, adding to difficulty in diagnosis in this population and contributing to delayed
diagnosis. Residents with dementia are at increased risk of scabies [14]. The highly contagious
crusted form of scabies is also difficult to recognise in RNC residents, where it may occur more
commonly due to misdiagnosis and treatment with corticosteroids. It presents with a hyper-
keratotic rash which may lack the characteristic itch and be more easily transmitted due to
high mite burden [9, 15].
Management of scabies outbreaks
An outbreak of scabies can be defined as two or more cases of classical scabies, or a single
case of crusted scabies, linked by time in the same environment [16]. The control of
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outbreaks in RNC is time-consuming and cost-intensive,
requiring mass treatment of infected cases and contacts. It is
complicated by issues including atypical presentation, close
proximity of residents, carers and visitors, mental capacity
issues, financial responsibility for treatment and logistical bar-
riers of mass treatment [15, 17, 18]. Here we focus on outbreaks
in RNCs only.
In the UK, existing national guidelines focus on management
of individual cases, and none exist for scabies outbreaks in
RNC [19]. In England, local Health Protection Teams (HPTs)
predominantly provide advice on the control of institutional
outbreaks using locally developed guidelines which are highly
variable in their recommendations [17]. No systematic review
has been undertaken of the effectiveness of interventions in
outbreaks.
Current drug treatments for scabies outbreak management
Drug treatments for scabies include topical acaricides (such as
benzyl benzoate, crotamiton, lindane, malathion, sulphur and
permethrin) and oral ivermectin, an anti-parasitic. A Cochrane
review of scabies treatments recommended topical permethrin,
but concluded ivermectin was an effective oral treatment [20].
Current National Institute for Health and Care Excellence
(NICE) guidelines for the treatment of individual cases of scabies
recommend permethrin 5% cream as first line treatment, and
malathion 0.5% aqueous liquid if permethrin is contraindicated
[19]. Treatment is applied to the whole body of all household
members and their close contacts, even if asymptomatic, left on
for 8–24 h and a second application 1 week later is recommended
[19]. Oral ivermectin is unlicensed but can be used on a
named-person basis [21]. Itch frequently persists following ther-
apy, and may not indicate treatment failure; symptomatic treat-
ment is recommended when needed [19].
Environmental management measures
There is some evidence of indirect scabies transmission through
fomites (clothing, bedding, furniture, carpet) [22], suggesting
environmental management measures including cleaning of
RNCs may have a role in preventing transmission. This transmis-
sion is thought to be rare with classical scabies but may occur with
the crusted form [1], though limited due to mites’ inability to sur-
vive off human skin for long periods [2, 9].
NICE guidelines recommend machine washing clothes, towels
and bed linen at 50 °C on the day of first treatment and referral of
institutional outbreaks to the HPT to advise on infection control
measures [19].
How can outbreak outcomes be measured? The need for a
framework
Outbreak measures must address the key dimensions described
above: timely diagnosis, drug treatment, environmental manage-
ment and symptomatic care.
Given the diagnostic and management challenges in RNC
described above, these must describe all points in the recognition
and treatment pathway in order to assess efficacy of interventions,
patient experience and how best to measure outbreak duration
and delayed recognition or intervention.
Outcome measures used in previous systematic reviews have
included the rate of treatment failure (persistence of original
scabies lesions, development of new lesions or identification of
mites on a skin scraping), number of new cases following treat-
ment [20], or need for repeat implementation of environmental
infection control measures. Figure 1 shows the points at which
delay may occur, which will inform this review.
In order to provide high-quality care, patients’ perception of
their care must be considered. Patient-Reported Outcome
Measures (PROMs) assess the efficacy of a treatment from the
patients’ perspective. PROMs in scabies infestation and manage-
ment may include duration or severity of itch, quality of sleep
and rate of secondary infection. Patient-Reported Experience
Measures (PREMs) evaluate the patients’ views of their experience
while being treated [23].
We undertook a systematic review of evidence on the effective-
ness of interventions for the management of scabies outbreaks
in RNC.
Aims
To systematically review evidence and determine how to best
manage scabies outbreaks in RNC. We address two empirical
research questions:
1. What is the most effective drug treatment for scabies outbreaks
in residential or nursing care homes for the elderly?
2. Which environmental infection control measures should be
undertaken to prevent further transmission and prolonged
infestation following an outbreak in this setting?
To inform future research, we also address methodological
research questions:
1. What are the most useful outcome measures in assessing the
effectiveness of scabies management measures?
2. How should delayed diagnosis and treatment be measured?
For the purposes of the current review, ‘elderly’ is defined as a
mean age of residents of over 65 years, where described.
Materials and methods
Search strategy
A literature search of four databases (PubMed, Cinahl, Embase
and Web of Science) was performed on 7 January 2017 and
repeated on 19 July 2017, using the terms ‘(((scabies OR crusted
scabies OR sarcoptes scabiei OR scabies mites)) AND (residential
home OR care home OR residential facility OR long term care
facility OR nursing home)) AND (treatment OR benzyl benzoate
OR permethrin OR ivermectin OR malathion OR lindane OR sul-
fur OR scabicide lotion OR infection control OR washing OR vac-
uum OR hoover OR cleaning OR carpet OR upholstery OR
bedding OR clothes OR isolation OR gloves OR aprons OR care
home closure)’.
Citations were retrieved from inception to the date of search.
Additional papers were identified using Google Scholar citation
searching and PubMed related articles. The PRISMA statement
was followed [24]. The search was carried out by two separate
reviewers (EJM and JEC). Search results were imported and stored
in EndNote Web, duplicates were removed and articles that were
not relevant, judged by titles and abstracts, were excluded. All
study designs were eligible for inclusion.
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Inclusion and exclusion criteria
Articles were eligible for inclusion if they met two criteria: (i)
studies of scabies outbreak management in RNC, and (ii) stud-
ies describing either drug treatment or environmental infec-
tion control measures implemented. Non-English language,
animal studies and those describing a scabies outbreak in
other settings, were excluded. Both reviewers screened search
results for compliance with the inclusion and exclusion cri-
teria; disagreements were discussed and resolved by consensus.
Quality assessment
All studies to be included in the review were assessed for
quality by the first author. We intended to assess the quality
of evidence and overall strength of recommendations using
the GRADE (Grading of Recommendations, Assessment,
Development and Evaluations Working Group) criteria [25].
However, GRADE differentiates poorly between the quality
of non-comparative observational studies, classifying them all
as low or very low quality evidence, so that any recommenda-
tions for the management of scabies outbreaks in RNC would
be weak based on the reports identified (see the ‘Results’
section).
A quality assessment tool was therefore developed from the
STROBE (Strengthening the Reporting of Observational Studies
in Epidemiology) checklist [26], to capture the quality of observa-
tional data for this review. A suite of 17 outcome measures con-
sidered suitable for these outbreaks was developed based on this
in the absence of a standard description.
Data extraction
Data items extracted included details of the population and set-
ting, number of cases identified, drug treatments and environ-
mental infection control measures implemented and outcome
measures reported.
Primary outcome measures were treatment failure of a con-
firmed case or need for repeat environmental measure implemen-
tation. The secondary outcome measure was duration of outbreak
(defined as time from identification of infestation of the index
case to successful treatment resulting in no new or repeat
cases). Adverse events were considered serious if life threating
or resulted in death or hospitalisation. Side effects including
those which required discontinuation of treatment or caused
patient discomfort or dissatisfaction were recorded.
The timescale of the outbreaks including date of first presen-
tation of symptoms or signs by a case, first correct diagnosis of
scabies, treatment of first diagnosed case and successful treatment
of all RNC cases were extracted where available in order to
describe duration of any delays in outbreak management.
Results
Literature search
A summary of the literature search is shown in Figure 2. Nineteen
studies were included in the review, dating back to 1983. All eval-
uated the drug treatment of scabies in RNC, and 10 also assessed
one or more environmental management measure. The included
studies are detailed in Table 1. Nearly all were excluded due to
not presenting primary data on an outbreak. These ranged from
Fig. 1. Outbreak measures in the timeline of a scabies outbreak in a RNC, including points in the diagnosis and management timeline where delay may occur.
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discussion pieces, editorials and educational articles. A few reported
outbreaks in settings that did not meet our inclusion criteria.
Quality assessment
Table 2 shows results of our assessment of included studies using
the STROBE derived quality assessment tool. Delays in manage-
ment and outbreak duration were identified through reporting
of dates of outbreak identification, management measure imple-
mentation and outbreak conclusion. No case report described
all 17 points, and seven reports were particularly poor [28, 29,
31, 33, 38, 39, 43], detailing less than 10 points.
Outcome measures
The reporting of outcome measures varied markedly. Two case
reports [28, 31] only discussed treatment of a single index case
after hospital admission for treatment and did not further
describe the outbreak. Five reports did not describe the rate of
treatment failure [28, 29, 31, 38, 39], and three did not report
the number of new cases diagnosed after treatment [28, 29, 31].
No definitions of treatment failure were given. Seven articles did
not report outbreak duration [28, 30, 31, 33, 36, 37, 44].
Notably, no PREMs or PROMs were reported in any outbreak.
Outbreak management delays
Delay in diagnosis or in successful treatment was described in all
but one case report in which the time scale of the outbreak was
not specified [38]. Twelve described a delay in diagnosis [16, 27,
28, 30, 31, 33, 34, 36, 37, 40, 42, 43], either stating there was a
delay or reporting the duration of time cases had symptoms before
a diagnosis of scabies was made. Fifteen reported a delay in effective
treatment [16, 27, 29, 30, 32, 33, 35–37, 39–44], due to treatment
failures or new cases following treatment. In eight studies [16, 27,
28, 31, 33, 36, 39, 40], misdiagnosis was reported. Though not all
Fig. 2. Flow of study selection at each stage from iden-
tification to final inclusion, including study numbers for
both drug treatment and environmental management
measures.
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articles specified the duration of delay; where reported, the median
duration from onset of symptoms to diagnosis was three months,
and median delay in effective treatment was 9 months.
Drug treatments
Over 800 cases of scabies were described in 19 studies. Drug treat-
ment of cases and prophylaxis of contacts (asymptomatic resi-
dents, staff and family) varied widely, as did success. Common
drug regimens were either topical treatment alone, topical treat-
ment in combination with oral ivermectin, or ivermectin alone.
A summary is provided in Table 3.
Permethrin cream was used first in four reports [16, 37, 38,
43], which resulted in two repeat cases in one report and
three repeat cases in another. These resolved with further per-
methrin application or oral ivermectin therapy. In two studies
other topical treatments were used initially (Lindane, benzyl
benzoate and crotamiton) with high levels of treatment failure,
before permethrin was used, resulting in resolution of the
outbreak [40, 44]. Of the 14 case reports where topical treat-
ments were used alone, oral ivermectin was required in three
for outbreak resolution [29, 32, 43]. In two case reports [37,
38], crusted scabies cases were identified and treated differently
from typical scabies, commonly with a combination of topical
treatment and oral ivermectin, which successfully ended the out-
break. Notably, in all case reports in which oral ivermectin
was used, it resulted in resolution of the outbreak [28, 29, 32,
34, 35, 41–43].
In 13 case reports [16, 28, 30, 32–37, 39, 40, 42, 44], all resi-
dents, staff and visiting contacts were treated. The rest varied
between residents only [29, 38, 41], confirmed cases [43] or con-
firmed cases and close contacts [27]. One report did not detail
who was treated [31]. Two reports also described a different treat-
ment regimen for residents (ivermectin) and staff or other con-
tacts (permethrin cream) [34, 35].
Excess death was reported by Barkwell et al. [29], in 6 months
following ivermectin treatment. Four other reports of ivermectin
use did not report this [32, 35, 37, 41]. There were six reports
Table 1. Summary of all studies included in the review, including outcome measures described in reports
Author Year Country
Setting (number of scabies
cases diagnosed) Outcome measures
Drug treatment/
environmental
measures/both
Andersen et al.
[27]
2000 Norway Three nursing homes (24) Number of cases before and after treatment,
repeat cases
Both
Apap et al. [28] 2012 Malta Residential home – treated in hospital
(unknown)
Time from diagnosis to successful treatment of
index case
Drug
Barkwell et al.
[29]
1997 Canada Long-term care facility (unknown) Outbreak duration Drug
Burns et al. [30] 1987 UK Residential home (4) Number of new cases after treatment Both
Chan et al. [31] 2000 Hong Kong Old-age home (9) Time from symptoms to successful treatment of
index case
Drug
Dannaoui et al.
[32]
1999 France Nursing home (7) Treatment failure and repeat cases, outbreak
duration
Both
De Beer et al. [16] 2006 South Africa Long-term care facility (57) Average duration of rash before treatment
initiation, outbreak duration
Both
Hetland et al.
[33]
1987 USA Nursing home intermediate care facility (41) Time from first symptoms to diagnosis, treatment
failure rate
Both
Ladbury et al.
[34]
2012 Netherlands Four elderly care homes as part of a wider
community outbreak (26)
Number of repeat cases or new cases after
treatment
Drug
Millership et al.
[35]
2002 UK Homes for the elderly mentally ill (19) Number of repeat cases or new cases after
treatment
Drug
Moberg et al. [36] 1984 Sweden Nursing home (14) Treatment failure and repeat cases Drug
Paasch et al. [37] 2000 Germany Three residences for the elderly (252) Treatment failure and repeat cases Both
Papini et al. [38] 1999 Italy Two nursing homes (91) Outbreak duration Drug
Parish et al. [39] 1983 USA Three nursing homes (unknown) Need for repeat treatment Drug
Paules et al. [40] 1993 USA Nursing home (6) Treatment failure and repeat cases, repeat
management measures, outbreak duration
Both
Sullivan et al.
[41]
1997 Australia Nursing home (33) Treatment failure and repeat cases Both
Van den Hoek
et al. [42]
2008 Netherlands Nursing home (5) Cases remaining symptom free at 3 months Both
Wilson et al. [43] 2001 USA Long-term care geriatric facility (15) Time to diagnosis, treatment failure Drug
Yonkosky et al.
[44]
1990 USA Three nursing homes (202) Treatment failure and repeat cases Both
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Table 2. Results of quality assessment tool adapted from the STROBE checklist for observational studies
Outcome measure
Author
[27] [28] [29] [30] [31] [32] [16] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44]
Study design and outbreak identification:
1. Description of study design − + − + + − + − + − + − − + + − + − −
2. Description of setting + + + + + + + + + + + + + + + + + + +
3. Description of how outbreak identified + + − + + + + + + + + + + + + + + − −
4. Method of case diagnosis described + + − + + + + + − + + + + + + + + + +
5. Number of individuals assessed for scabies + − − + − + − + − − + + + + + + − − +
6. Characteristics of cases (demographic, clinical, social) − − + + − − + − + + + + + − + − + + +
7. Number of cases reported + − − + + + + + + + + + + − + + + + +
Efficacy of management measure:
8. Full description of treatment including who treated and why + − + + − + + + + + + + + + + + + + +
9. Full description of EMMs implemented + − − + − + + + − − − + − − + + + − +
10. Number of repeat cases observed after treatment + − + + − + + + + + + + − − + + + + +
11. Number of new cases observed after treatment + − − + − + + + + + + + − − + + + + +
12. Adverse events or side effects reported − − + − − + − − − + + + − + − + − − +
Management delay:
13. Date of outbreak identification reported + − + − − + + − + + − − + − + − + + +
14. Date of mass treatment±environmental management implementation − − + − − + + + − + − − − − + − + − −
15. Date outbreak declared over reported + − + − − + + − + + − − + − + − + + −
Patient Experience measures:
16. PROMs/PREMs reported (severity/duration of itch, quality of sleep, secondary
infection etc.)
− − − − − − − − − − − − − − − − − − −
17. Description of symptomatic treatment given − − + − + − − − − − − + − + − − − − −
Total 11 4 9 11 6 13 13 10 10 12 11 12 9 8 14 10 13 9 11
+ Represents criteria achieved.− Represents criteria not achieved.
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of increased pruritus following scabies treatment with ivermectin
[35, 41], Tenutex [36], allethrin spray [37], lindane [39] and per-
methrin [44].
Symptomatic relief
One report described the use of crotamiton cream for symptom-
atic relief of persistent pruritus following treatment [39],
and another described re-treatment if pruritus persisted beyond
initial anti-scabies treatment [37]. In two outbreaks crotamiton
was used as part of the treatment regimen [29, 31]; while other
reports did not describe any symptomatic treatment for itch.
Environmental management measures
Ten reports described implementation of environmental measures
to aid in outbreak control. Description of these varied widely,
with some reports outlining protocols and others briefly stating
RNC cleaning took place. The most commonly reported measures
were ‘spray or disinfection of the infested persons’ environment’
and ‘washing of clothes’.
A summary of environmental management measures reported
is presented in Table 4. Only two reports described protocols for
the timing of these in relation to treatment [37, 41]. Two others
described repeat cleaning or infection control measures following
treatment [27, 33]. Despite reporting requiring additional drug
treatment for treatment failures in seven of the 10 articles, only
one reported repetition of environmental management measures
in association with repeat treatment [32].
Discussion
This systematic review reveals a moderate number of reports of
the management of scabies outbreaks in RNC, but the absence
of comparative studies assessing either drug treatment or environ-
mental management. Permethrin was reported to be an effective
treatment for scabies outbreaks in RNC, resulting in just five
repeat cases. While lindane was also a commonly used topical
treatment, further anti-scabies treatment was required in four of
the seven outbreaks in which it was used. It was not possible to
determine the effects of environmental management measures
on any of the outcome measures in this review due to the lack
of comparative studies. The quality of the data presented is low,
and outcome measures used in previous literature (e.g. rate of
treatment failure or duration of outbreak) were often missing.
This limits the value of this observational evidence, which is
much weaker than it need be. Outcomes within studies are poorly
documented, with PROMs and PREMs almost entirely absent.
Consequently, no clear recommendations can be made about
the effectiveness of drug or environmental interventions for out-
breaks in RNC (beyond NICE guidelines for individuals). The rec-
ommendation in recent German guidelines [15], for permethrin
with ivermectin as an alternative appear reasonable pending bet-
ter evidence, especially given that individual comparison of lin-
dane with permethrin shows it to be inferior [45]. There is
clearly an urgent need for comparative, preferably randomised
studies of the various drug treatments used, and these should
include detailed description of all elements in the pathway from
recognition of an index case through to evaluation of the effective-
ness of outbreak control.
Despite the poor quality of data reporting, it was notable that
delay in recognition or treatment of outbreaks was almost univer-
sally reported, with almost half of reports describing initial
misdiagnosis. This is consistent with recent reports of RNC
experience [6]. While RNC is a difficult setting to access for out-
break research [46], which is necessarily done in a hurry, high-
quality studies of interventions for infectious diseases in care
homes can be achieved [14, 47].
Table 3. Summary of drug treatments implemented in reports. Alternative treatments used due to new cases arising following treatment or unresolved cases. Note
some RNCs reported the use of different drug treatments for different residences affected
Number of reports in which
treatment used first line
Number of reports in which
alternative needed Alternative treatment used
Topical treatments
Lindane 7 4 Ivermectin, crotamiton,
permethrin
Permethrin 5% cream 4 1 Ivermectin
Benzyl benzoate 3 1 Permethrin
Crotamiton 3 2 Ivermectin, permethrin
Tenutex 1 0
Allethrin spray 1 0 Ivermectin for crusted
scabies
Topical treatment in combination with
oral treatment
Lindane + ivermectin 1 1 Ivermectin + permethrin
Malathion, permethrin + ivermectin 1 0
Permethrin + ivermectin 1 0
Oral treatment only
Ivermectin 3a 0
Tenutex = DDT 0.5%, disulphiram 2%, benzyl benzoate 22.5%; commercial purified form of GBHC (gamma benzene hexachloride) is lindane, therefore results combined.
aStaff and contacts were treated with topical permethrin in all three reports.
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The poor data quality we observed also highlights the import-
ance of using comprehensive and consistent data collection strat-
egies to describe and analyse delay. This could be through the
framework we present in Figure 1, which has been operationalised
in our multi-outbreak report describing the clinical features of
outbreaks in RNC [14]. The quality assessment tool we adapted
from the STROBE checklist used to capture the quality of obser-
vational data in this review may also be more widely applicable, to
better differentiate studies where randomised controlled trials or
controls are lacking.
It is less clear how an evidence base for environmental mea-
sures should be developed, especially given the uncertainty
about drug treatments with which they will necessarily interact.
Experiments on the survival of the scabies mite off its human
host under the range of environmental conditions found in the
RNC setting could inform the maximum time period after contact
when decontamination is worth considering, while veterinary
data may address in part the likely increased transmissibility of
crusted scabies. A recent review by Arlian et al. [48] concluded
that disinfection should not be necessary and isolation of the
bed, bedding and clothing for 48 h should be sufficient.
However, this would be challenging in RNC, and little evidence
exists to support this from human studies. This is an urgent ques-
tion for RNC – one report identified drug treatment as just one-
fifth of the cost associated with the outbreak, with the majority of
cost due to staff overtime, disposable gowns and gloves, cleaning
supplies and laundry services [16].
As so often in reports of infectious disease outbreaks, these
case reports did not systematically address PREMs which are
essential in the development of guidelines as they assess patients’
objective experience of care and determine acceptability of a man-
agement strategy from a patient perspective. Although PREMs
may be difficult to assess in this setting where many residents
may be cognitively impaired, they must still be considered and
reported where possible. In six reports increased pruritus was
noted as a side effect following scabies treatment with a range
of drugs. It is recognised that itch may persist for several weeks
following scabies treatment [11], yet few reports recognised this
and failed to describe whether symptomatic treatment was given
alongside anti-scabies treatment. Drug treatments used for itch
include topical crotamiton, topical hydrocortisone or oral
antihistamines [19]. In order to address resident comfort and
reduce suffering, symptomatic relief should be considered in
future evidence-based guidelines.
In many outbreaks all residents, staff, family and contacts were
treated and multiple treatment failures were ascribed to the lack of
a highly-coordinated management plan. Whilst there are no UK
national guidelines on scabies outbreaks in RNC [17], NICE
guidelines for other cases of scabies infestation recommend sim-
ultaneously treating all household and close contacts [19].
Despite this advice, a recent systematic review by Fitzgerald
et al. [49] found there is currently no evidence for the use of
prophylactic treatment to prevent infestation in contacts.
Patterns of exposure are likely to differ between family households
and RNC, and the question of contact treatment should be
addressed in future comparative trials of drug treatments.
One report by Barkwell et al. [29] described an increase in
mortality in 6 months following ivermectin therapy in RNC resi-
dents. This cross-sectional study comparing deaths in a fixed per-
iod after ward level topical treatment and ivermectin mass
treatment in two long stay wards has been heavily criticised due
to the failure to control for factors leading to ward allocation
and other confounders including other treatments, and it is not
possible to conclude any increase in mortality is the result of iver-
mectin therapy [50, 51]. These results have not been replicated in
any other study of ivermectin in RNC [32, 35, 37, 41, 51], a drug
which is used worldwide in the mass treatment of river blindness
(onchocerciasis) and serious adverse effects reported are rare [21].
This study reports only peer reviewed studies and it is possible
that outbreak reports in the grey literature of similar quality may
have been missed by our search strategy. We only included studies
reported in English, and it is possible that comparative studies
were missed. We did not review veterinary studies or experiments
on mite survival which may be needed to specify and describe
environmental interventions.
Overall, this review has highlighted a lack of comparative stud-
ies assessing the optimal drug treatment or necessary environ-
mental management measures for outbreak control in RNC.
Current observational evidence is weak and the evidential value
of future studies could be improved through better reporting of
outbreak outcome measures, such as time to diagnosis and time
to effective treatment, as these incorporate any diagnostic delay
Table 4. Summary of environmental management measures implemented in reports
Environmental management measure
Author
[27] [30] [32] [16] [33] [37] [40] [41] [42] [44]
Isolation of cases + + + + − − − − − −
Use of gowns±gloves + + − + + + − − − −
Handwashing between care + − − − − − − − − −
Long sleeves worn + − − + − − − − − −
Washing of clothes + − + + + + + + + +
Spray or disinfection of environment + + − + + + + + + +
Upholstery/bed linen washed, frozen or bagged + − + + + + + − +
Visitor ban − − − + − − − − − −
Suspend admissions − − − + + − − − − −
+ Represents measure implemented.− Represents measure not implemented or not described.
Where information regarding a measure was not provided in the text, the report was scored as not achieving said point (−).
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or delay in effective treatment, which was common within reports.
Patient-reported outcome and experience measures of treatment
are important in the consideration of future national guidelines
for managing these outbreaks and should be prioritised in future
studies.
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